THERAPEUTICS Oral antiplatelet agents clopidogrel and prasugrel for the prevention of cardiovascular events

被引：2
|
作者：
Passacquale, Gabriella [1 ]
Ferro, Albert [1 ]
机构：
[1] Kings Coll London, Dept Clin Pharmacol, Div Cardiovasc, London SE1 9NH, England
来源：
BMJ-BRITISH MEDICAL JOURNAL | 2011年 / 342卷
关键词：
PERCUTANEOUS CORONARY INTERVENTION; MYOCARDIAL-INFARCTION; COST-EFFECTIVENESS; ASPIRIN; THERAPY;
D O I：
10.1136/bmj.d3488
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页数：8
相关论文
共 50 条
  • [1] An Appraisal of Dual Antiplatelet Therapy with Clopidogrel and Aspirin for Prevention of Cardiovascular Events
    Terpening, Chris
    [J]. JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2009, 22 (01) : 51 - 56
  • [2] Antiplatelet Agents in Cardiology: A Report on Aspirin, Clopidogrel, Prasugrel, and Ticagrelor
    Dobesh, Paul P.
    Varnado, Sara
    Doyle, Meagan
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (13) : 1918 - 1932
  • [3] Antiplatelet agents and cardiovascular prevention
    Barry, S
    Mercier, S
    [J]. THERAPIE, 1997, 52 (01): : 53 - 58
  • [4] Oral antiplatelet agents in cardiovascular disease
    Pultar, Joseph
    Wadowski, Patricia P.
    Panzer, Simon
    Gremmel, Thomas
    [J]. VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE, 2019, 48 (04) : 291 - 302
  • [5] Role of antiplatelet drugs in the prevention of cardiovascular events
    Tendera, M
    Wojakowski, W
    [J]. THROMBOSIS RESEARCH, 2003, 110 (5-6) : 355 - 359
  • [6] Clopidogrel, Prasugrel, or Ticagrelor? A Practical Guide to Use of Antiplatelet Agents in Patients With Acute Coronary Syndromes
    Norgard, Nicholas B.
    DiNicolantonio, James J.
    [J]. POSTGRADUATE MEDICINE, 2013, 125 (04) : 91 - 102
  • [7] Oral anticoagulant and antiplatelet drugs used in prevention of cardiovascular events in elderly people in Poland
    Beata Labuz-Roszak
    Krystyna Pierzchala
    Michal Skrzypek
    Marta Swiech
    Agnieszka Machowska-Majchrzak
    [J]. BMC Cardiovascular Disorders, 12
  • [8] Oral anticoagulant and antiplatelet drugs used in prevention of cardiovascular events in elderly people in Poland
    Labuz-Roszak, Beata
    Pierzchala, Krystyna
    Skrzypek, Michal
    Swiech, Marta
    Machowska-Majchrzak, Agnieszka
    [J]. BMC CARDIOVASCULAR DISORDERS, 2012, 12
  • [9] Aspirin or clopidogrel for secondary prevention of cardiovascular events: Is there a winner?
    Gaspoz, JM
    de Moerloose, P
    [J]. AMERICAN JOURNAL OF MEDICINE, 2004, 116 (12): : 850 - 852
  • [10] Differential Impact of Diabetes Mellitus on Antiplatelet Effects of Prasugrel and Clopidogrel
    Niijima, Satoshi
    Ohmori, Tsukasa
    Kario, Kazuomi
    [J]. CIRCULATION, 2017, 136
12345